{
  "ptid_time": "129_S_4287_2013-10-22",
  "img_path": "/data/qiuhui/data/adni/images/129_S_4287/2013-10-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,980 mm³, 35.9% below the reference mean. With a Z-score of -0.82 (20.5th percentile), this represents normal volume ; hippocampal volume measures 7,662 mm³, 7.7% above the reference mean. With a Z-score of 0.71 (76.0th percentile), this represents normal volume ; whole brain volume measures 947,965 mm³, 2.7% below the reference mean. With a Z-score of -0.34 (36.5th percentile), this represents normal volume . ",
  "text_data": "Age is 72.9 years. Gender is Female. Education: 17 years. MMSE: 28.0. MoCA: 26.0. Logical Memory: 3.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.49 SUVR (profound elevated); Amyloid beta: 698.40 pg/mL (normal ); Total tau: 418.60 pg/mL (significant elevated); Phosphorylated tau: 47.40 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The brain volumes (ventricular, hippocampal, and whole brain) are within normal ranges, and the MMSE and MoCA scores are also normal, indicating no significant cognitive impairment. However, the elevated T-tau, P-tau, and AV45 levels suggest significant amyloid and tau pathology, which are biomarkers for Alzheimer's disease.  \nDiagnosis: MCI (Mild Cognitive Impairment)  \nConfidence: Medium  \n\n(Note: While the cognitive scores are normal, the biomarker profile is strongly suggestive of early Alzheimer's pathology, which may precede clinical symptoms. This could indicate preclinical Alzheimer's or very early MCI. However, without clear cognitive decline, the diagnosis remains MCI with medium confidence.)",
  "timestamp": "2025-07-26T14:15:06.763347"
}